ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Astrana Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.90+0.09 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
Share price
+$4.89 (+15.28%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Astrana Health, Inc. grew revenue 58.9% to $3.84B over the twelve months to Jun 30, 2026. Operating income rose 43.4% to $100.46M, moving the operating margin from 2.9% to 2.6%. Free cash flow was $94.38M, down 22.2% from a year earlier.
Revenue
$3.84B
+58.9% vs. a year earlier
Operating income
$100.46M
+43.4% vs. a year earlier
Free cash flow
$94.38M
-22.2% vs. a year earlier
EPS, diluted
$0.82
+57.7% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.84B
- P/E ratio
- 45.0
- Price to sales
- 0.48
- Price to book
- 2.21
- Dividend yield
- –
- Free cash flow yield
- 5.14%
Fundamentals
- Revenue
- $3.84B
- Net income
- $40.55M
- EPS, diluted
- $0.82
- Free cash flow
- $94.38M
- Book value per share
- $16.68
- Diluted shares
- 50M
Fourteen years at a glance
Fiscal years 2010 to 2025 and trailing twelve months, USD
Revenue
$3.84B+58.9% YoY
Gross profit
$402.00M+47.1% YoY
Operating income
$100.46M+43.4% YoY
Net income
$40.55M+60.5% YoY
EPS, diluted
$0.82+57.7% YoY
Free cash flow
$94.38M-22.2% YoY
Reported periodTrailing twelve months